Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 94: 119-127, 2003. First published September 27, 2002; doi:10.1152/japplphysiol.00044.2002
8750-7587/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
94/1/119    most recent
00044.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Muylem, A.
Right arrow Articles by Paiva, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Muylem, A.
Right arrow Articles by Paiva, M.
Vol. 94, Issue 1, 119-127, January 2003

Modeling of impact of gas molecular diffusion on nitric oxide expired profile

Alain Van Muylem1, Claire Noël2, and Manuel Paiva2

1 Department of Chest Medicine, Erasme University Hospital, and 2 Biomedical Physics Laboratory, Université Libre de Bruxelles, 1070 Brussels, Belgium


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Present descriptions of nitric oxide (NO) transport in the lungs use two compartment models: airway compartment without mixing and alveolar compartment with perfect mixing. These models neglect NO molecular diffusion in the airways. To assess the impact of axial diffusion on expired NO profile, we solved a transport equation that incorporated diffusion, convection, and NO sources in the symmetrical Weibel model of the lung. When NO parameters computed from experimental data with the two compartment models are used in our model as NO sources, simulated end-expired NO is 29-45 and 64-78% of experimental values at expiratory flows of 50 and 2,000 ml/s, respectively. These lower values are because of NO axial diffusion: During expiration, NO back diffusion (opposed to convection) prevents some NO from being expired, so a two- to fivefold increase of airway NO excretion is necessary to simulate end-expired NO consistent with experimental data. We conclude that, insofar as a significant amount of NO is produced in small airways, models neglecting NO axial diffusion underestimate excretion in the airways.

gas transport model; nitric oxide production


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

DURING THE LAST FEW YEARS, several models have been used for the interpretation of exhaled nitric oxide (NO). Tsoukias and George (13) and Pietropaoli et al. (8) proposed qualitatively similar models that had an airway and an alveolar compartment. They can account, for example, for the marked flow dependence of end-expired NO concentration (10). NO concentration in airspaces results from a balance between 1) excretion from tissues, 2) diffusion into blood, and 3) ventilation. By parametric model fitting on experimental NO curves as a function of expired flow and independent measurement of NO diffusion into blood, Pietropaoli et al. separately assessed airway and alveolar contributions to NO excretion (QNO). Nevertheless, the models of both Pietropaoli et al. and Tsoukias and George neglect transport by axial molecular diffusion between airways and alveoli. This mechanism necessarily participates on concentration homogenization, especially at low flow rate, because it transports NO molecules from the airway to the alveolar compartment, which results in less NO molecules available for expiration.

Using a model of gas transport that includes convection (bulk flow) and axial molecular diffusion (6) in a geometry derived from the symmetrical model of Weibel (17), we propose to assess the influence of axial diffusion on exhaled NO in two types of experiments: the expired flow dependence on end-expired NO (by using several tests, each with constant expired flow) and the NO expiration profile with change of expired flow, i.e., a variable flow during expiration (14, 15).


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

General Equation of Transport in a Symmetrical Model of the Lung

Transport of NO by diffusion and convection in a symmetrical model of the lung can be described by
<FR><NU>∂C</NU><DE>∂<IT>t</IT></DE></FR> = D<FR><NU>s</NU><DE>S</DE></FR> <FR><NU>∂<SUP>2</SUP>C</NU><DE>∂<IT>x</IT><SUP>2</SUP></DE></FR> + <FR><NU>D</NU><DE>S</DE></FR> <FR><NU>∂s</NU><DE>∂<IT>x</IT></DE></FR> <FR><NU>∂C</NU><DE>∂<IT>x</IT></DE></FR> − <FR><NU>1</NU><DE>S</DE></FR> <FR><NU>∂(<A><AC>Q</AC><AC>˙</AC></A>C)</NU><DE>∂<IT>x</IT></DE></FR>  (1)

− <FR><NU>C</NU><DE>V</DE></FR> <FR><NU>∂V</NU><DE>∂<IT>t</IT></DE></FR> + <FR><NU>1</NU><DE>V</DE></FR> (<A><AC>Q</AC><AC>˙</AC></A><SUB>NO</SUB> − D<SUB>NO</SUB> · C)
where t is time, x is axial distance (x = 0 corresponds to the alveolar end) of the model, C(x,t) is NO concentration, and D is the molecular diffusion coefficient. S(x,t), s(x,t), V(t), Q(x,t) are total cross-sectional area (airways + alveoli), airway total cross-sectional area, volume, and axial flow, respectively. D was taken to equal 0.22 cm2/s (13). This model has been accepted as a good tool to provide a realistic description of gas concentration profiles in the lung periphery when anatomical asymmetry is neglected (2).

The last term of Eq. 1 is the NO source term: the difference between QNO (in ml/s) and NO diffusion into blood (-DNO · C) per unit volume. DNO is expressed in ml · s-1 · ppb-1. We separate airways and alveoli contributions to QNO and DNO as
<A><AC>Q</AC><AC>˙</AC></A><SUB>NO</SUB>(<IT>x</IT>) = <A><AC>Q</AC><AC>˙</AC></A><SUB>NOAw</SUB>(<IT>x</IT>) + <A><AC>Q</AC><AC>˙</AC></A><SUB>NOAl</SUB>(<IT>x</IT>)

D<SUB>NO</SUB>(<IT>x</IT>) = D<SUB>NOAw</SUB>(<IT>x</IT>) + D<SUB>NOAl</SUB>(<IT>x</IT>)
where QNOAw and QNOAl are airway and alveolar QNO, respectively, and DNOAw and DNOAl are airway and alveolar NO transfer factor, respectively.

Geometrical Boundaries

Geometrical boundaries were derived from the symmetrical model of Weibel (17), i.e., from generation 0 (trachea x = 27 cm) to generation 23 (alveolar end x = 0 cm), each generation being characterized by a length, a total cross-sectional area and an airways total cross-sectional area. The preinspiratory volume of the model is 3,700 ml.

Numerical Computation

Equation 1 was solved numerically as a function of time with the model discretized in n nodes separated by 0.02 cm and with each variable being computed at each node i (i = 1, 2, ... 1,357). The boundary conditions are C = 0 at the model entry, because there is no NO inspired, and partial C/partial x = 0 at the model end (6).

Source Terms

We assume that excretion from tissues and diffusion into tissues and blood are uniformly distributed over airways and alveolar wall areas. Thus airway excretion and diffusion in a node i are the overall airway excretion and diffusion multiplied by the airway wall area in node i divided by the total airway wall area. Alveolar excretion and diffusion at node i are computed the same way.

Airway and alveolar wall areas at node i are computed as follows.

Airways. At node i belonging to generation n, the airway wall area is computed as the lateral surface of a cylinder of radius ri (17) and length equal to 0.02 cm (internodal distance), multiplied by 2n. Toward the alveolar end, the airway wall surface decreases dramatically and becomes nil at the level of the alveolar ducts. On the basis of Weibel's data, the total airway wall area is equal to 2.2 m2 (17).

Alveoli. The alveolar wall surface at node i (Aalvi) may be approximated by
A<SUB>alv<IT>i</IT></SUB> = 0.02(S<SUB><IT>i</IT></SUB>−s<SUB><IT>i</IT></SUB>)s<SUB>a</SUB>/v<SUB>a</SUB>
where 0.02(Si - si) is the total alveolar volume at node i, and sa/va is the ratio between the wall surface and the volume of an alveolus. In the present model, the total alveolar wall area is equal to 75 m2.

Figure 1 shows the percentage of the surface of airway walls (A) and of alveolar walls (B) as a function of the distance from alveolar end and of generation number in generations 7-23. Generation 17 is the first generation with alveoli, and generation 21 is the last with airway walls.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   Distribution of airway (A) and alveolar wall (B) area as a function of axial distance from alveolar end and of generation number. Distributions are expressed as percentage of the total area.

Numerical Values of NO Parameters

Flow dependence of end-expired NO. Table 1 shows the parameters chosen as the source terms. These are the means of values deduced from seven subjects with an airway-alveolus compartment model (8).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Parameters for simulations of flow dependence of end-expired NO

Dynamic change of flow during a single exhalation. NO parameter values are summarized in Table 2. QNOAw and DNOAw are given by Tsoukias et al. (14) and correspond to the individual experimental curve shown on Fig. 5 of their article. For this subject, they also deduced a steady alveolar NO concentration (alveolar QNO/alveolar DNO) of 1.82 ppb. With alveolar DNO = 1.46 × 10-6 ml · s-1 · ppb-1 (Table 1), we have alveolar QNO = 2.66 × 10-6 ml/s.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Parameters for simulations of dynamic change of flow during a single exhalation

General Conditions for the Simulations

All simulations assume a NO-inspired concentration that is equal to zero. The initial condition (before the test) of NO concentration inside the model is the steady-state concentration profile obtained after five sequential tidal breaths, i.e., 500-ml inspiration followed by 500-ml expiration both at a constant flow of 500 ml/s. This initial condition is the equivalent of the NO inside the lung of a subject before performing any NO test. With this initial condition, two types of test were simulated.

Flow dependence of expired NO. In these simulations, inspiratory and expiratory volumes were always 1 liter, inspiratory flow was always 500 ml/s, and expiratory flow varied. We considered the NO concentration value at the onset of the model after 1 liter expired (the end of expiration in our simulations) as the output variable. In the following, the term "end-expired NO concentration" refers to this output variable. For expired flows of 50 and 2,000 ml/s, we performed 1) simulations with a uniformly distributed NO production and 2) simulations with weighted contribution of generations 0 to 2 to QNO. Keeping the overall NO airway excretion given in Table 1, we determined, by successive iterations, the weighting of the three first generations necessary to obtain, with an expiratory flow of 50 ml/s, a midexpired (10 s after the beginning of expiration) concentration at the onset of generation 3 roughly equal to 50% of the concentration at the onset of generation 0 (9). In the following, the term "nonuniform NO production" always refers to simulations with this generation 0-2 weighting.

We also performed simulations with expiratory flows of 50, 125, 250, 500, 1,000, and 2,000 ml/s, respectively, considering either a uniform and a nonuniform NO production, the expiratory volume being always 1 liter. The same simulations were performed by assuming D = 0 in Eq. 1 (no axial diffusion).

Dynamic change of flow during a single exhalation. With the above defined initial conditions, we considered one inspiration of 4.4 s with 500 ml/s flow, followed by a breath hold of 20 s (zero flow in Eq. 1), followed by a 17-s expiration. The expired flow pattern mimics the experiment depicted on Fig. 5A of Tsoukias et al. (14), i.e., a linear decrease from 420 to 140 ml/s for the first 3.9 s, a linear decrease from 140 to 70 ml/s for the next 5.7 s, and a linear decrease from 70 to 50 ml/s for the remaining 7.4 s. We performed simulations by considering uniform and nonuniform NO production, respectively.

Differences Between Simulation and Recommended Experimental Procedures

In standardized experimental procedures, it is recommended (12) to inhale to total lung capacity and to expire at a constant flow until a NO concentration plateau is reached. This plateau is measured for at least 3 s during an expiration of at least 6 s, and the percentage difference between its lower and upper limits has to be <10%. Our simulation procedure in the constant flow tests differs from the recommended one (12) by a smaller inspired volume, a fixed expired volume, and an output variable defined as a single NO concentration value after 1 liter has expired. To estimate the deviation introduced by this simulation procedure, we performed simulations with 3 liters inspired and an expired plateau measured according to the recommended procedures (12). We considered expired flows of 50 and 2,000 ml/s, considering uniform and nonuniform NO production, respectively. Because 6-s expiration is unrealistic at 2,000 ml/s, we considered 2.5-s expiration and a plateau measured over 1.5 s.

Influence of End-Inspiration Breath Hold on End-Expired NO Concentration

We performed simulations with 20-s breath hold (zero flow in Eq. 1) between inspiration and expiration. These simulations were performed with the NO parameters of Table 1 at constant expired flows of 50 and 2,000 ml/s, respectively, and for both uniform and nonuniform NO production.

Sensitivity to NO Parameters

Flow dependence of expired NO. We performed double pairs of simulations as described in Flow dependence of expired NO, at a constant expired flow of 50 and 2,000 ml/s, respectively, in the following situations: 1) DNOAw = 0; 2) QNOAw of Table 1 multiplied by two and five, respectively; and 3) QNOAw of Table 1 multiplied by five and alveolar QNO = 0, only for uniform NO production.

Dynamic change of flow during a single exhalation. Again, when we considered both uniform and nonuniform NO production, we performed simulations as described in Dynamic change of flow during a single exhalation in the following situations: 1) DNOAw = 0 and DNOAw of Table 2 multiplied by two, respectively; and 2) QNOAw of Table 2 multiplied by two and five, respectively, for uniform NO production and multiplied by two for nonuniform NO production.

We have also analyzed the early peak of expired NO concentration after a 20-s breath hold. We considered as indexes the peak value and the amount of NO expired in this early phase, i.e., the area under the NO-expired profile as a function of volume from the onset of expiration to the minimum value of expired NO (trough before the sloping profile). Simulations with D = 0 were also performed, with the values of Table 2 for both uniform and nonuniform NO production.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Figure 2 shows the NO concentration profiles at mid-expiration, for an expiratory flow of 50 ml/s. Curve 1 is the curve obtained with a uniform distribution of NO production. Curve 2 corresponds to a weighted contribution of generations 0 to 2 to NO production. The weighting was computed to obtain a concentration value at the onset of generation 3 (arrow at 7 cm of axial distance) approximately equal to half the concentration value at the model onset (arrow at 27 cm of axial distance). This corresponds to a contribution of generations 0 to 2 of 20% of total QNOAw.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2.   Nitric oxide (NO) concentration profiles at midexpiration as a function of axial distance from alveolar end for a constant expiratory flow of 50 ml/l, obtained by solving Eq. 1. Curve 1 corresponds to uniform distribution of NO production. Curve 2 corresponds to weighting NO production in generations 0 to 2 (see text for details). Vertical arrows indicate the onset of generation 0 (Gen 0)and onset of generation 3 (Gen 3). ppb, Parts per billion.

Figure 3 shows NO concentration profiles as a function of the axial distance from alveolar end for generations 7 to 23 (Fig. 3A) and NO expired concentration at the onset of the model as a function of time (Fig. 3B). In Fig. 3A, we show the initial conditions before the test (curve 1), end-inspiratory concentration (curve 2), and concentration after a 20-s breath hold (curve 3). In Fig. 3B, curves 1 and 2 represent concentration without and with a 20-s breath hold, respectively. These simulations were performed with 2 s of inspiration and 2 s of expiration at a constant flow of 500 ml/s.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3.   A: NO concentration in generations 7 to 23 as a function of axial distance from alveolar end obtained by solving Eq. 1. Curve 1 is the initial NO profile before inspiration. Curve 2 is the NO profile after 2-s inspiration at a constant flow of 500 ml/s. Curve 3 is the NO profile after a 20-s breath hold. B: NO concentration at the onset of generation 0 as a function of time during expiration at a constant flow of 500 ml/s. Curves 1 and 2 are NO expiratory profiles without and with a 20-s breath hold, respectively.

Figure 4 shows the NO concentration profiles in generations 7 to 23 during inspiration (Fig. 4A) and expiration (Fig. 4B) as a function of the axial distance every 0.2 s (no breath hold). Curve at t = 0 (Fig. 4A) corresponds to curve 1 of Fig. 3A. Curves at t = 2 s (Fig. 4A) and t = 0 (Fig. 4B) correspond to curve 2 of Fig. 3A.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   NO concentration profiles in generations 7 to 23 during inspiration (A) and expiration (B) as a function of axial distance from alveolar end obtained by solving Eq. 1 with constant inspiratory and expiratory flows equal to 500 ml/s. Curves are shown every 0.2 s (from 0 to 2 s). A: curve at time (t) = 0 is the steady-state profile before the test (curve 1). B: curve at t = 0 is the NO profile after 2-s inspiration at 500 ml/s (curve 2).

Differences Between Simulation and Recommended Experimental Procedures

Differences in percentage between NO plateau measured according to recommended procedures (12) and end-expired NO concentration described in General conditions for the simulations are -9.0% (-0.71 ppb) and 2.5% (<0.01 ppb) for 50 and 2,000 ml/s, respectively, with uniform NO production and -4.3% (-0.51 ppb) and 2.5% (<0.01 ppb) for 50 and 2,000 ml/s, respectively, with nonuniform NO production.

Simulation of Experiments

Flow dependence of expired NO. Table 3 gives the experimental results derived from the data of Pietropaoli et al. (8) and Tsoukias and George (13) (lines 1 and 2, respectively) and summarizes the results of the simulations for expiratory flows of 50 and 2,000 ml/s, respectively, both for uniform and nonuniform NO production (lines 3 to 9).

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Experimental and simulated end-expired NO

Figure 5 shows simulations and experimental results for all expired flows. Gray zone and dashed line are the range and the mean values of end-expired NO computed from experiments on seven healthy subjects (8). Corresponding close and open symbols are simulated values with and without axial diffusion (D = 0 in Eq. 1), respectively. Circles and squares corresponds to uniform and nonuniform NO production, respectively.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 5.   End-expired NO as a function of (constant) expired flow. The gray zone and the dashed line are the range and mean of experimental values, respectively (see text for details).  and open circle , Obtained by solving Eq. 1 with Table 1 values for NO parameters, with [NO molecular diffusion coefficient (D) = 0.22 cm2/s] and without (D = 0) axial diffusion, respectively, and uniform NO production.  and , Values corresponding to  and open circle , respectively, with nonuniform NO production.

Dynamic change of flow during a single exhalation. Figure 6 shows the expired NO concentration profile as a function of time with the decreasing expired flow pattern described above, i.e., linear decrease from 420 to 140 ml/s for the first 3.9 s, a linear decrease from 140 to 70 ml/s for the next 5.7 s, and a linear decrease from 70 to 50 ml/s for the remaining 7.4 s. The gray outline on each panel is the experimental curve from Fig. 5 of Tsoukias et al. (14). Figure 6A corresponds to simulations with uniform NO production: curve 1 (solid line) with the NO parameters of Table 2; curve 2 (dotted line) with the assumption that D = 0; curves 3 and 4 (dashed lines) correspond to QNOAw multiplied by two and five, respectively. The arrows indicate the corresponding peak values at the onset of expiration. Simulations 1, 2, and 3 shown in Fig. 6B are the equivalent of those in Fig. 6A but for nonuniform NO production. The peaks are out of scale, and their values are indicated explicitly beside the vertical arrows.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Expired NO concentration as a function of time with a decreasing expired flow (see text for details). Solutions of Eq. 1 are considered with uniform (A) and nonuniform (B) NO production. Gray outlines show experimental curves (14). Curve 1 (solid line) on both panels was obtained by solving Eq. 1 with Table 2 NO parameters values. Curve 2 on both panels (dotted line) was obtained by assuming D = 0 in Eq. 1. A: curves 3 and 4 (dashed lines) considered NO production in the airways (QNOAw) from Table 2 multiplied by 2 and 5, respectively. Horizontal arrows show peak NO concentration for each curve B: curve 3 (dashed line) considered QNOAw from Table 2 multiplied by 2. The peak of curves 1, 2, and 3 are out of scale, and their numerical values are given beside the vertical arrows.

Table 4 gives the peak values and the areas under the peak (NO amount) without molecular diffusion (lines 3 and 9) and when NO parameters differ from Table 2 (lines 4 to 7 and 10 to 12).

                              
View this table:
[in this window]
[in a new window]
 
Table 4.   Experimental and simulated NO peak and NO peak amount


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Compartmental models, such as those previously used to describe NO transport (8, 11, 13), have been very useful to interpret several tests in respiratory physiology. However, they use differential equations that only allow computation of time-dependent concentrations in each compartment. Present simulations correspond to solutions of Eq. 1, which is a partial differential equation and enables the consideration of simultaneous convection and diffusion that operate in a structure based on the symmetrical lung model of Weibel (17).

The focus of the present work is the impact of molecular diffusion on expired NO. Molecular diffusion plays a major role in gas transport in the periphery of the lung because of it being dominant in the zone peripheral to the terminal bronchioles (6). During normal breathing, it is negligible in the conducting airways. A study of Silkoff et al. (9) suggests that, in normal subjects, a large part of NO production in the airways comes from the zone between upper trachea and main bronchi. Thus, other than simulations with uniformly distributed NO production, as in compartmental models, we considered nonhomogeneous NO production by weighting the upper generations' contribution. Figure 2 shows concentration profiles at midexpiration as a function of axial distance. Curve 1 corresponds to uniformly distributed NO production, and curve 2 corresponds to a weighting of generations 0 to 2, both with the overall QNO in the airways given in Table 1. In our model, the latter case corresponds to consider 20% of NO production on generations 0 to 2, which represent <1% of the total epithelial surface. When we used the source term with values given by Pietropaoli et al. (8) (Table 1) and Tsoukias and George (13) (Table 2), the simulations qualitatively reproduce experimental findings with a smaller end-expired NO when expired flow increases (Fig. 5) (10). The NO-expired profile shows an early peak followed by a typical slope (Fig. 6) when flow decreases during a single expiration after a 20-s breath hold (14, 15). However, there is a quantitative difference between these simulations and experiments. Figure 5 shows that end-expired NO concentration is below the experimental range at any expired flow and far from the mean experimental value, especially at low flows, regardless of whether we consider a larger NO production in the first generations. Figure 6 shows that the simulated profile with the NO parameters of Table 2 (curve 1 on each panel) is below the experimental curve (gray outline on each panel). Insofar as our model describes NO transport in a more realistic way than compartment models, this disagreement may come from inadequate estimation of NO exchange parameters used in Eq. 1.

The link between the two-compartment models and our model can be done by considering D = 0 (no diffusion) in Eq. 1 with the same NO parameters (Tables 1 and 2). In this case, end-expired NO concentrations (open circles and squares on Fig. 5) are close to experimental values. Similarly, for a decreasing expired flow, the expired-NO profile becomes close to the experiments when D = 0 (curve 2 in Fig. 6, A and B). This shows the importance of molecular diffusion on NO transport, even when a larger NO production in the first generations is considered (Table 3, lines 3 and 4).

Tsoukias and George (13) pointed out the potential role of diffusion on alveolar concentration during breath hold. Indeed, Fig. 3A shows that alveolar concentration is greater after a 20-s breath hold (curve 3). However, as can be seen on Table 3 (lines 3 and 5), a 20-s breath hold has a limited impact on end-expired NO as it was shown experimentally (4). Our simulations stress the fact that diffusion plays an active role during the complete respiratory cycle, mainly during expiration. This is illustrated in Fig. 4, which shows typical concentration profiles during inspiration (Fig. 4A) and expiration (Fig. 4B) for equal time intervals as a function of distance from alveolar end. From the onset of the acinus (~1 cm from alveolar end) down to the alveolar end, there is a concentration gradient established almost immediately after the beginning of expiration that results in a backdiffusion flow toward the alveolar zone and consequently a continuous increase of NO concentration. During most of the expiration, the shape of the NO concentration profile changes very little and represents a quasi-stationary diffusion front of NO equivalent to the diffusion front of inert gases (6). This rapid quasi-stationarity during both inspiration and expiration explains that, in our simulations, NO concentration after 1 liter is expired differs little (<1 ppb at 50 ml/s) from the NO plateau measured according to recommendations for standardized procedures (12). The diffusion and convection flows are explicitly shown in Fig. 7, A and B, as functions of distance from the alveolar end at midexpiratory time at 2,000 and 50 ml/s, respectively. It appears that in both cases diffusion flow is toward alveoli (negative value) in the acinar zone. This flow transports NO molecules into the alveolar zone, with some of them diffusing into blood instead of being expired. By comparing Fig. 7, A and B, one may see that the backdiffusion flow increases when expiratory flow decreases and that it overcomes convection at low flow (Fig. 7B). This explains why the difference of end-expired NO between simulations incorporating diffusion and simulations assuming D = 0 (lines 3 and 4 of Table 3, respectively) is much greater at low flow. Increasing NO production in the first three airway generations, where diffusion is negligible, diminishes not only the relative amount of NO molecules "lost" by backdiffusion but also the NO peripheral production. The former phenomenon dominates at 50 ml/s by increasing end-expired NO by 55%; the latter phenomenon dominates at 2,000 ml/s by decreasing end-expired NO by 18% (Table 3, line 3).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 7.   Simulated convection (dashed lines) and diffusion (solid lines) NO flows as a function of axial distance from the alveolar end of the model. Negative values are flow toward alveoli, and positive values are flow toward mouth. A and B correspond to a constant expiratory flow of 2,000 and 50 ml/s, respectively. Simulated flows are shown at midexpiration, i.e., at 0.25 s (A) and at 10 s (B). Values of NO parameters are given in Table 1.

As the two-compartment models do not incorporate backdiffusion flow, they implicitly assume that all NO molecules excreted and not recaptured by blood circulation are transported by convection and expired. Use of these models to fit experimental data underestimates NO sources, especially in the airways and particularly at low flows.

The purpose of this work is to show the importance of diffusion and not to fit experimental data. However, we have estimated the impact of NO parameter variation on expired NO. One may achieve a greater concentration in the airways either by increasing QNOAw or decreasing NO transfer (DNOAw). The latter has little effect: For uniform NO production and in the extreme situation where DNOAw is equal to zero (line 6 of Table 3), end-expired NO concentration increases by 13% only at an expired flow of 50 ml/s. On the contrary, for uniform NO production, two- and fivefold increases in QNOAw increase end-expired NO concentration by 74 and 292%, respectively, at 50 ml/s and by 36 and 142%, respectively, at 2,000 ml/s (lines 7 and 8 of Table 3). When nonuniform NO production is considered, two- and fivefold increases in the QNOAw increase end-expired NO concentration by 83 and 332%, respectively, at 50 ml/s and by 26 and 139%, respectively, at 2,000 ml/s (lines 7 and 8 of Table 3). An increase factor between two and five would allow simulations to mimic experimental values (Table 3).

In regard to the test proposed by Tsoukias et al. (14), Fig. 6A (uniform NO production) shows that the experimental NO profile after the early peak (gray outline on each panel) lies between two curves (curves 3 and 4) simulated with an airway excretion two and five times the value of Table 2, respectively. In Fig. 6B (nonuniform NO production), curve 3 (simulated with an airway excretion two times the value of Table 2) is close to the experimental curve after the peak. However, these simulations show the limits of the model in the present form: The shape of the early peak of concentration resulting from NO accumulation in the airways during a 20-s breath hold is clearly not reproduced. The simulated peak is always sharper than in experiments (Fig. 6) and larger when nonuniform NO production is considered (Fig. 6B and Table 4, lines 8 to 12). Molecular diffusion tends to decrease the peak value (Table 4, lines 2, 3, 8, and 9) and to increase its sharpness (Fig. 6). Without any mixing process, the amount of NO produced during breath hold parallels the relative epithelial surface (Fig. 1A), which gives a high NO concentration between generations 13 and 17. During expiration, this peak is spread over a relatively large volume. The diffusion process prevents NO concentration from rising during breath hold in this peripheral zone (Fig. 3A, curve 3) so that the maximum NO value is smaller and located in the first generations. The peak at expiration is thus smaller and sharper since it is spread over a smaller volume. Given that the NO peak comes from the first generations, its relative insensitivity to DNOAw is not surprising (Table 4 lines 4, 5, 10, and 11). The insensitivity is because of the very low proportion of epithelial surface of the first generations relative to the total surface (Fig. 1A), given a very low transfer factor per unit volume in this zone. From this, it can be seen that the NO concentration in the first generations before expiration is mainly determined by diffusion, QNOAw, and breath-hold time. If we consider the amount of NO that is accumulated during breath hold, i.e., the area under the peak, instead of the peak value, the result of line 12 of Table 4, (QNOAw × 2 and a nonuniform NO production) approaches the experimental value. This is consistent with results presented on Table 3 (line 7) and Fig. 6B (curve 3) and suggests that this would be the most suitable combination of parameters to mimic experiments in normal subjects. Nevertheless, the great difference in shape between simulated and experimental NO peak suggests that some other phenomena may play a role in the first generations, such as convective mixing (including in the mouth cavity), asymmetry of the main bronchi (3), and inhomogeneous ventilation combined or not with sequential emptying. Further simulations should address these issues specifically.

The major impact of backdiffusion flow on expired NO is a consequence, in our model, of the dramatic increase of epithelial surface peripheral to generation 13 (Fig. 1A), giving a large NO production in this zone where molecular diffusion becomes the dominant mode of transport (6). This may be questioned. Findings of Silkoff et al. (9) and in vitro measurements (5, 16) suggest that, in normal subjects, NO production may be lesser in peripheral airways and larger in central bronchi. On the other hand, Dubois et al. (1) estimated that NO production occurs throughout the first 450 ml of the airways, which in the Weibel model includes, at least, respiratory bronchioles. We showed (Table 3, line 3) that a weighting of NO production in the first generations compatible with the findings of Silkoff et al. (10) does not abolish the impact of molecular diffusion.

It is worth noting that the results presented here are slightly influenced by NO production in the alveoli. If we assume NO production to be nil for a given airway excretion (lines 8 and 9 of Table 3), end-expired NO decreases by only 3.5% (1.1 ppb) and 25% (1.8 ppb) at 50 and at 2,000 ml/s, respectively. Even in the absence of any NO source in the alveoli, NO molecules coming from the airways during inspiration (by convection and diffusion) and during expiration (by backdiffusion) ensures a nonzero NO value in the alveoli. This result questions the computation of an alveolar excretion value from the estimated equilibrium alveolar concentration and an independent measurement of alveolar DNO, as proposed by some authors (7, 8).

The present work is only theoretical, and the predicted role of diffusion on NO transport has to be established experimentally. This could be done by measuring early peak and end-expired NO at low flow and after lung equilibration with gas mixtures, which leads to very different diffusion coefficients for NO. This can be achieved by comparing NO expiratory profile when 20% of oxygen is mixed with 80% helium and 80% sulfurhexafluoride, respectively.

In summary, we simulated end-expired NO as a function of flow and NO profile as a function of time with a decreasing expiratory flow by using a model of gas transport that includes source terms, convection, and molecular diffusion. Our simulations predict that, insofar as NO production occurs in peripheral airways, axial diffusion has a major impact on expired NO and that neglecting this mechanism may lead to underestimating QNO parameters in the airways. A smaller production in the peripheral airways would temper these conclusions, but, even if further studies show a lower effect of molecular diffusion in the normal subject, the backdiffusion mechanism would remain crucial for the interpretation of increased exhaled NO due to peripheral inflammation (4).


    ACKNOWLEDGEMENTS

This work was supported by the Federal Office for Scientific Affairs ("Prodex" program).


    FOOTNOTES

Address for reprint requests and other correspondence: A. Van Muylem, Dept. of Chest Medicine, Erasme Univ. Hospital, Route de Lennik, 808, B-1070 Brussels, Belgium (E-mail: avmuylem{at}ulb.ac.be).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

September 27, 2002;10.1152/japplphysiol.00044.2002

Received 17 January 2002; accepted in final form 18 September 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   DuBois, AB, Kelley PM, Douglas JS, and Mohsenin V. Nitric oxide production and absorption in trachea, bronchi, bronchioles, and respiratory bronchioles of humans. J Appl Physiol 86: 159-167, 1999[Abstract/Free Full Text].

2.   Engel, LA. Dynamic distribution of gas flow. In: Handbook of Physiology. The Respiratory System. Mechanics of Breathing. Bethesda, MD: Am. Physiol. Soc, 1986, vol. III, p. 575-594, sect. 3, pt. 2, chapt. 32.

3.   Horsfield, K, and Cumming G. Functional consequences of airway morphology. J Appl Physiol 24: 384-390, 1968[Free Full Text].

4.   Kharitonov, SA, Chung FK, Evans D, O'Connor BJ, and Barnes PJ. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med 153: 1773-1780, 1996[Abstract].

5.   Kobzik, L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, and Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 9: C371-C377, 1993.

6.   Paiva, M. Gas transport in the human lung. J Appl Physiol 35: 401-410, 1973[Free Full Text].

7.   Perillo, IB, Hyde RW, Olszowka AJ, Pietropaoli AP, Frasier LM, Torres A, Perkins PT, Forster RE, 2nd, Utell MJ, and Frampton MW. Chemiluminescent measurements of nitric oxide pulmonary diffusing capacity and alveolar production in humans. J Appl Physiol 91: 1931-1940, 2001[Abstract/Free Full Text].

8.   Pietropaoli, AP, Perillo IB, Torres A, Perkins PT, Frasier LM, Utell MJ, Frampton MW, and Hyde RW. Simultaneous measurement of nitric oxide production by conducting and alveolar airways of human. J Appl Physiol 87: 1532-1542, 1999[Abstract/Free Full Text].

9.   Silkoff, PE, McClean PA, Caramori M, Slutsky AS, and Zamel N. A significant proportion of exhaled nitric oxide arises in large airways in normal subjects. Respir Physiol 113: 33-38, 1998[ISI][Medline].

10.   Silkoff, PE, McClean PA, Slutsky AS, Furlott HG, Hoffstein E, Wakita S, Chapman KR, Szalai JP, and Zamel N. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 155: 260-267, 1997[Abstract].

11.   Silkoff, PE, Sylvester JT, Zamel N, and Permutt S. Airway nitric oxide diffusion in asthma: role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 161: 1218-1228, 2000[Abstract/Free Full Text].

12.   Slutsky, AS, and Drazen JM. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide nasal nitric oxide in adults and children: 1999. Am J Respir Crit Care Med 160: 2104-2177, 1999[Free Full Text].

13.   Tsoukias, NM, and George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 85: 653-666, 1998[Abstract/Free Full Text].

14.   Tsoukias, NM, Shin HW, Wilson AF, and George SC. A single-breath technique with variable flow rate to characterize nitric oxide exchange dynamics in the lungs. J Appl Physiol 91: 477-487, 2001[Abstract/Free Full Text].

15.   Tsoukias, NM, Tannus Z, Wilson AF, and George SC. Single-exhalation profiles of NO and CO2 in humans: effect of dynamically changing flow rate. J Appl Physiol 85: 642-652, 1998[Abstract/Free Full Text].

16.   Watkins, DN, Peroni DJ, Basclain KA, Garlepp MJ, and Thompson PJ. Expression and activity of nitric oxide synthases in human airway epithelium. Am J Respir Cell Mol Biol 16: 629-639, 1997[Abstract].

17.   Weibel, ER. Morphometry of the Human Lung. New York: Academic, 1963.


J APPL PHYSIOL 94(1):119-127
8750-7587/03 $5.00 Copyright © 2003 the American Physiological Society



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
V. Suresh, D. A. Shelley, H.-W. Shin, and S. C. George
Effect of heterogeneous ventilation and nitric oxide production on exhaled nitric oxide profiles
J Appl Physiol, June 1, 2008; 104(6): 1743 - 1752.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. Verbanck, Y. Kerckx, D. Schuermans, W. Vincken, M. Paiva, and A. Van Muylem
Effect of airways constriction on exhaled nitric oxide
J Appl Physiol, April 1, 2008; 104(4): 925 - 930.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Kerckx, A. Michils, and A. Van Muylem
Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients
J Appl Physiol, April 1, 2008; 104(4): 918 - 924.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. C. George
How accurately should we estimate the anatomical source of exhaled nitric oxide?
J Appl Physiol, April 1, 2008; 104(4): 909 - 911.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. Condorelli, H.-W. Shin, A. S. Aledia, P. E. Silkoff, and S. C. George
A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model
J Appl Physiol, January 1, 2007; 102(1): 417 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H.-W. Shin, P. Condorelli, and S. C. George
Examining axial diffusion of nitric oxide in the lungs using heliox and breath hold
J Appl Physiol, February 1, 2006; 100(2): 623 - 630.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H.-W. Shin, P. Condorelli, and S. C. George
A new and more accurate technique to characterize airway nitric oxide using different breath-hold times
J Appl Physiol, May 1, 2005; 98(5): 1869 - 1877.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. F. Gelb, C. F. Taylor, E. Nussbaum, C. Gutierrez, A. Schein, C. M. Shinar, M. J. Schein, J. D. Epstein, and N. Zamel
Alveolar and Airway Sites of Nitric Oxide Inflammation in Treated Asthma
Am. J. Respir. Crit. Care Med., October 1, 2004; 170(7): 737 - 741.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H.-W. Shin, P. Condorelli, C. M. Rose-Gottron, D. M. Cooper, and S. C. George
Probing the impact of axial diffusion on nitric oxide exchange dynamics with heliox
J Appl Physiol, September 1, 2004; 97(3): 874 - 882.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. Condorelli, H.-W. Shin, and S. C. George
Characterizing airway and alveolar nitric oxide exchange during tidal breathing using a three-compartment model
J Appl Physiol, May 1, 2004; 96(5): 1832 - 1842.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. C. George, M. Hogman, S. Permutt, and P. E. Silkoff
Modeling pulmonary nitric oxide exchange
J Appl Physiol, March 1, 2004; 96(3): 831 - 839.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
94/1/119    most recent
00044.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar